Elevated mean platelet volume levels have been presumed to be linked to metabolic disorders and cardiovascular diseases, although a causative relationship has never before been proven. In this study, researchers evaluate the relationship between mean platelet volume and metabolic syndrome in patients with type 2 diabetes mellitus.
Adhering to regular physical activity and a healthy diet in midlife is associated with a reduced risk for metabolic syndrome.
Central hypothyroidism occurs as a result of a poorly functioning thyroid stimulating hormone (TSH) that only reaches low to normal levels. In this featured study, researchers examine whether levothyroxine treatment can raise TSH levels and resolve metabolic issues.
Study authors performed a retrospective review of a thyroid cancer cohort to evaluate the association between metabolic health and severity of thyroid cancer.
High systemic total cholesterol in early middle age may play a role in initial development of AMD.
The researchers’ goal was to assess whether appetite-related hormones — fasting leptin, ghrelin, glucagon-like peptide-1, peptide YY — can predict the risk for weight regain.
A comparative list of medications by pharmacological class for the treatment of obesity.
Metabolic syndrome (MetSyn) is prevalent among patients with psoriasis and is associated with increased cardiovascular risk.
Sucrose, or common table sugar, is not as effective as glucose in signaling postprandial satiation.
Many bariatric surgery patients do not receive recommended postoperative nutritional and weight monitoring within general practice.
